Navigation Links
Sarasota's Roskamp Institute Announces Positive Safety Data in,Human Clinical Study for Alzheimer's Disease

m Alzheimer's as it did in the pre-clinical studies on mice.

"While the Roskamp Institute and team of top neuroscience researchers in Ireland are still in the early phases of studying Nilvadipine, it is a great accomplishment that at this stage we are seeing such a strong safety profile in our patients," said Dr. Fiona Crawford, Associate Director of the Roskamp Institute.

Meanwhile other researchers in Japan are independently reporting results that support the idea that Nilvadipine will be useful for treating Alzheimer's disease. Patients in the early stages of the disease have shown increases in blood flow to the brain and did better on memory tests when treated with Nilvadipine compared to another antihypertensive drug, Amlodipine.

"These early results are encouraging and allow us to proceed with studies looking more closely at whether this drug is going to be useful to slow down or prevent this dreadful disease." Dr. Mullan added.

The Roskamp Institute is devoted to understanding causes of, and finding cures for, diseases of the mind like neuropsychiatric and neurodegenerative disorders and addictions. The Institute utilizes a broad range of scientific approaches to understanding the causes of and potential therapies for these disorders with an emphasis on Alzheimer's disease.

For more information please contact the Roskamp Institute in Sarasota (941) 752-2949, the Roskamp Institute Memory Center in Tampa (813) 979-2008, or visit us online at http://www.RoskampInstitute.com.

CONTACT: Sarah Bascom or Kristen Bridges of The Roskamp Institute,+1-850-222-2140

Web site: http://www.RoskampInstitute.com/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2

Related medicine technology :

1. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
2. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
3. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
5. Southern Research Institute to Present at the 2007 American Association For Cancer Research Annual Meeting
6. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
7. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine

Post Your Comments:
(Date:11/6/2009)... -- Philips Respironics applauds the efforts of th... to raise awareness about an important public heal... release of the first-ever government study to mon...s a milestone in quantifying the size and scope of...stry leader and sleep therapy manufacturer, Philip...
(Date:11/6/2009).../ -- Cyberonics, Inc. (Nasdaq: CYBX ) today annou...s for the second quarter ended October 23, 2009 of...y, November 18, 2009 at 5:00 PM EST. The company ...sults on Thursday, November 19, 2009 at 9:00 AM ES... Conference Call Instructions ,, To listen to...
(Date:11/6/2009)... , - Trial Will Compare NXL103 With Leadi...-Resistant Staphylococcus Aureus (MRSA) Infections...ompany focused on the discovery and,development of...icant global,problem of microbial resistance, anno...ial NXL103 (flopristin/linopristin), has started a...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 1Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 2Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 3Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 4Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 5Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 6Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 7Angiotechs Licensee Cook Medical Announces CE Mark Approval and European Launch of the Zilver 28R 29 PTX 28R 29 Stent 13489 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 1DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 2DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 3DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 4DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 5DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 6DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 7DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 8DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 9DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 10DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 11DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 12DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results 54154 13Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 1Rockport Healthcare Group Continues to Grow Coverage Area With New Work Comp Network Certification in Georgia 54149 2
...e many, clinical studies are few, NEW YORK, Aug. ...that a limited amount of clinical research exists,...r (OTC) anti-aging,products. The study is publishe...urgery Journal, the official peer-reviewed journal...gery (ASAPS). OTC anti-aging products represent a...
...tional Stem,Cell Holding, Inc. (OTC: NHGI.PK), tod...y, and Jacob Cohen, have discovered biomaterial de...s to promote tissue repair in,various wound care a...ced that while using its,proprietary embryonic ste...,group of biomaterials that in preclinical studies...
Other Medicine Technology:OTC Anti-Aging Products: Hype or Hope? 2National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair 2National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair 3
(Date:11/7/2009)...d for Life Action endorses a key vote today on the...Dahlkemper-Lipinski-Smith Amendment, an Amendment ...on in health care reform. ,, Americans United for ...t said, "Americans United for Life Action strongly...mper-Lipinski-Smith Amendment to prohibit abortion...
(Date:11/7/2009)...uth will rebel, expert says , , SATURDAY, ...o behave badly if their parents expect them to, a ...hey are simply being realistic might actually cont...hanan, a psychology professor at Wake Forest Unive...sity news release. "Negative expectations on the p...
(Date:11/7/2009)...-25th marked the 12th annual tournament bringing t...e against pediatric cancer. Stephen Updegraff, MD...r many years. , St. Peter...d of October 23-25 marked the 12th annual tournam...ting the battle against pediatric cancer– To...
(Date:11/7/2009)...quo;sweatox’ or ‘Boytox’, the ne...i-ageing jab ‘Breastox’ – or bre...colletage, can reduce the appearance of wrinkles a...sts, leaving smoother, younger-looking skin. , ...Transform, the UK’s largest group of cosmet...
(Date:11/6/2009)...ER, Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pharm...d that it will report financial results for the th...g of Monday, November 9, 2009. Cardiome will hold ...n (6:00am Pacific) on that day to discuss the resu... 416-695-7806 or 888-789-9572 and reference confer...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 3Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3
...A new study has found that single tablets containi...olling increasing blood pressure in people with e...al study named ACCOMPLISH (Avoiding Cardiovascular...niversity of Michigan Medical School. As p...
...Stanford University School of Medicine researchers...of the body's immune system known as troublemaker...ficial for metabolism. The new finding is ...eputation for being the bad guys. We have found th...
...The lives of laborers begin from mines and end wit...desh. Forced to work in illegal stone quarries b...o silica dust puts the laborers at high risk of ge...villages of Madhya Pradesh's Morena district. ...
...A new study has found that apart from using mobile...f passengers in a vehicle could increase the risk...itute for International Health, was intended to de...und that passengers also contribute to road accide...
...Addressing the concerns of developing countries li...World Health Organization (WHO), has promised eff...istribution of pandemic influenza vaccines at affo... A resolution on those lines is being adopted by t...
...One almost freezes in horror watching the ghastly ...ocks, on the ground then, covering her head as sto...shed with a concrete block, blood oozes from her h...ad, 17, was to love a boy from another religion. S...
Other Medicine News:Health News:Single-tablet With Two Drugs may Help Control High BP Better 2Health News:Macrophages may Help Prevent Obesity 2Health News:Miners in Madhya Pradesh at High Risk of Developing TB 2Health News:Not Only Mobile Phones, Even Passengers can Increase the Risk of Road Accidents 2Health News:WHO Announces Deal on Sharing Bird Flu Virus 2Health News:Women in Iraq More Unsafe Than Ever 2
...AREDS formula is the one and only vitamin and mine...nstitute's age-related eye study (AREDS) 10-year t...cal Age-Related Eye Disease Study (AREDS) by the N...Institutes of Health) showed that a unique vitamin...
Ocuvite® Eye Vitamins and Mineral Supplement
...aps, the patented next-generation dietary suppleme...systemically address the root inflammatory cause a... peer-reviewed literature that these specific nutr...ther affected parts of the body, such as mucous me...
...the industry-leading portal to QC information, pro... way to access their quality control data and othe...b enables Bio-Rad customers to access on-demand (I...s, as well as convenient online data entry and man...
Medicine Products: